Similarly, TG-101348 or JSI-124, the specific inhibitor of JAK2, could also mitigate the myocardial fibrosis induced by hypoxia, but the vehicle has no such effects (Figures 7A–E). Here, JAK2 is linked to Myocardial fibrosis.